IONS Ionis Pharmaceuticals, Inc.
IONS Ionis Pharmaceuticals, Inc.
Healthcare · Biotechnology
Market read
Scan convergence 1 scan as of 2026-10-16 1 bear converging
POC $74.64 · VWAP $67.35 · -36.3% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
2 watchlists
IONS Price Structure
Loading timeframes…
Peers
Every watchlist IONS belongs to, members best 30-day change first — IONS highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@ibb
@biotech-scan
Reported the quarter ending 2026-06-30: revenue $268M, diluted EPS -$0.69, net income -$115M (SEC filing). Across the print the stock moved -1.1% (close before → first close after).
full note →Against street estimates
How IONS's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
News (last pull)
Headlines about IONS from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 28 days ago · Sep 19
- Ionis Pharmaceuticals (IONS) Stock Price, News & Analysis
- Ionis Pharmaceuticals - IONS - Stock Price Today - Zacks
- Ionis Pharmaceuticals, Inc. (IONS) Earnings Dates & Report ...
- Ionis Pharmaceuticals (IONS) Earnings Date and Reports 2026
- IONS News Today | Why did Ionis Pharmaceuticals stock go down today?
IONS research tape
47 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.